关注
Anchala Kumari
Anchala Kumari
Jawaharlal Nehru University, TERI school of Advanced Studies
在 terisas.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis
N Kumar, A Awasthi, A Kumari, D Sood, P Jain, T Singh, N Sharma, ...
Journal of Biomolecular Structure and Dynamics 40 (1), 101-116, 2022
572022
Role of pncA gene mutations W68R and W68G in pyrazinamide resistance
M Aggarwal, A Singh, S Grover, B Pandey, A Kumari, A Grover
Journal of cellular biochemistry 119 (3), 2567-2578, 2018
362018
Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework
N Kumar, N Admane, A Kumari, D Sood, S Grover, VK Prajapati, ...
Scientific Reports 11 (1), 7653, 2021
352021
Natural polyphenolic inhibitors against the antiapoptotic BCL-2
S Verma, A Singh, A Kumari, C Tyagi, S Goyal, S Jamal, A Grover
Journal of Receptors and Signal Transduction 37 (4), 391-400, 2017
352017
Conformational ensembles of α-synuclein derived peptide with different osmolytes from temperature replica exchange sampling
S Jamal, A Kumari, A Singh, S Goyal, A Grover
Frontiers in Neuroscience 11, 684, 2017
272017
Synergistic approaches unraveling regulation and aggregation of intrinsically disordered β-amyloids implicated in Alzheimer’s disease
A Kumari, R Rajput, N Shrivastava, P Somvanshi, A Grover
The International Journal of Biochemistry & Cell Biology 99, 19-27, 2018
252018
Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin
A Kumari, VS Rajput, P Nagpal, H Kukrety, S Grover, A Grover
Journal of Biomolecular Structure and Dynamics 40 (11), 4987-4999, 2022
242022
In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus
J Jain, A Kumari, P Somvanshi, A Grover, S Pai, S Sunil
F1000Research 6, 2017
232017
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis
A Singh, A Singh, S Grover, B Pandey, A Kumari, A Grover
Gene 641, 226-234, 2018
202018
Alanine mutation of the catalytic sites of Pantothenate Synthetase causes distinct conformational changes in the ATP binding region
B Pandey, S Grover, S Goyal, A Kumari, A Singh, S Jamal, J Kaur, ...
Scientific reports 8 (1), 903, 2018
202018
Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
A Kumari, R Sharma, N Shrivastava, P Somvanshi, A Grover
RSC advances 10 (43), 25929-25946, 2020
182020
Gene disruption reveals a dispensable role for plasmepsin VII in the Plasmodium berghei life cycle
BS Mastan, A Kumari, D Gupta, S Mishra, KA Kumar
Molecular and biochemical parasitology 195 (1), 10-13, 2014
182014
1, 3, 4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus
F Naaz, A Khan, A Kumari, I Ali, F Ahmad, BA Lone, N Ahmad, IA Khan, ...
Bioorganic Chemistry 113, 105031, 2021
132021
HHV-5 epitope: A potential vaccine candidate with high antigenicity and large coverage
N Kumar, A Singh, S Grover, A Kumari, P Kumar Dhar, R Chandra, ...
Journal of Biomolecular Structure and Dynamics 37 (8), 2098-2109, 2019
132019
Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes
A Kumari, P Somvanshi, A Grover
RSC advances 10 (21), 12166-12182, 2020
92020
Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants
S Verma, S Goyal, A Kumari, A Singh, S Jamal, A Grover
PloS one 13 (2), e0190942, 2018
92018
Insight into the inhibitor discrimination by FLT 3 F691L
S Verma, A Singh, A Kumari, B Pandey, S Jamal, S Goyal, S Sinha, ...
Chemical Biology & Drug Design 91 (5), 1056-1064, 2018
82018
Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins
VS Rajput, R Sharma, A Kumari, N Vyas, V Prajapati, A Grover
Journal of Biomolecular Structure and Dynamics 40 (19), 9096-9113, 2022
62022
Inhibitory mechanism of an antifungal drug, caspofungin against amyloid β peptide aggregation: Repurposing via neuroinformatics and an experimental approach
A Kumari, N Shrivastava, M Mishra, P Somvanshi, A Grover
Molecular and Cellular Neuroscience 112, 103612, 2021
62021
Structural basis for isoniazid resistance in KatG double mutants of Mycobacterium tuberculosis
A Rabha, A Singh, S Grover, A Kumari, B Pandey, A Grover
Microbial pathogenesis 129, 152-160, 2019
52019
系统目前无法执行此操作,请稍后再试。
文章 1–20